Xalatan prescribing information |
|
 |
|
2008;52(3):114-9.
Stefan C, Dumitrica DM.
Spitalul Clinic de Urgenta Militar Central, Bucuresti, Sectia Clinica de Oftalmologie. CSTEFAN58@YAHOO.COM
[Ocular surface disfunction in glaucoma] [Article in Romanian]
PURPOSE: To determine the effects of travoprost 0.004% and latanoprost 0.005% treatment on ocular surface in primary open angle glaucoma (POAG) patients. METHODS: Clinical, observational prospective study, during 6 months on two groups of patients newly diagnosed with POAG. Group I (10 patients) was treated with travoprost 0.004% and group II (10 patients) was treated with latanoprost 0.005%. The groups were homogeneous about age and sex, exclusion criteria being any ocular or general associated pathology Routine ophthalmic examination was performed before and after treatment. At each examination was performed Schirmer 1 test and break up time test. Conjunctival cytology specimen was taken and goblet cells density evaluated. RESULTS: There was statistically significant difference in goblet cell density Schirmer 1 test and BUT test before and after treatment (p<0.05). For the both groups the decrease of IOP was similar (from 23.7+/-1.5 mmHg to 15.4+/-1.7 mmHg in group I and from 24.3+/-1.5 mmHg to 15.8+/-1.7 mmHg in group II). CONCLUSIONS: This study showed that travoprost 0.004% and latanoprost 0.005% treatment can have adverse effects on ocular surface and may give rise to dry eye symptoms.
2008 Dec;17(8):667-73.
Aptel F, Cucherat M, Denis P.
Department of Ophthalmology, Edouard Herriot Hospital, Lyon, France. aptel_florent@hotmail.com
Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
2008 Nov;53 Suppl1:S107-20.
Toris CB, Gabelt BT, Kaufman PL.
Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5840, USA. ctoris@unmc.edu
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
2008 Dec 3;9:69.
Eyawo O, Lee CW, Rachlis B, Mills EJ.
Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada. edeyawo@yahoo.com
Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.
2007 Nov;29(11):2468-76.
Martikainen JE, Häkkinen U, Enlund H.
Research Department, The Social Insurance Institution, Helsinki, Finland. jaana.martikainen@kela.fi
Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment.
2007;51(2):81-6.
Chiselitã D; Pentru Eastern European Start Study Group.
Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
2007 Nov;23(11):2867-75.
Schmier JK, Covert DW, Robin AL.
Exponent Inc., Alexandria, VA 22314, USA. jschmier@exponent.com
Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective.
2007 Aug;23(4):359-65.
Sutton A, Gilvarry A, Ropo A.
Guildford Clinical Pharmacology Ltd., Guildford, Surrey, United Kingdom. asutton@gcpl.co.uk
A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males.
2007 Oct;144(4):520-4. Epub 2007 Aug 9.
Lee PP, Walt JG, Chiang TH, Guckian A, Keener J.
Duke Eye Center, Duke University, Durham, North Carolina, USA. lee00106@mc.duke.edu
A gap analysis approach to assess patient persistence with glaucoma medication.
Adv Ther. 2004 Jul-Aug;21(4):203-13.
University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Efficacy of latanoprost and timolol maleate in black and white patients.
J Glaucoma. 2005 Apr;14(2):157-160.
Kaiserman I, Kaiserman N, Nakar S, Vinker S.
From the *Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel; daggerDepartment of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and double daggerDepartment of Family Medicine, Clalit He
The Effect of Combination Pharmacotherapy on the Prescription Trends of Glaucoma Medications.
Xalatan review article...
|
|
Cataract and glaucoma
 Xalatan prescribing information
Buy here
|
|
My Basket
